The airway epithelium is a critical site for binding and entry of the SARS and NL63 coronaviruses throughinteractions with their receptor angiotensin converting enzyme 2 (ACE2). ACE2, a terminal carboxypeptidase, is expressed on the apical surface of the epithelial cells that line conducting airways, as well as alveolar epithelial cells. ACE2 is released from the surface of epithelia into airway surface liquid (ASL) via cleavage by TACE (ADAM17) and other sheddases. This soluble ACE2 (sACE2) is catalytically active in ASL, although its native substrates and biologic funcfions are poorly understood. ACE2 appears to have other functions that include induction of epithelial cell signaling and defense function, and SARS-CoV S protein or SARS virus infection directly downregulate pulmonary ACE2 expression. Loss of pulmonary ACE2 function has been hypothesized to contribute to acute lung injury associated with SARS, sepsis, and acid aspiration. The overall goal of this project is to better understand how the expression and release of ACE2 is governed in ainway epithelia, using models of well-differentiated human airway epithelia and mouse models of SARS-CoV infection, and relate this to SARS-CoV pathogenesis. Our overall hypothesis is that changes in pulmonary ACE2 expression and activity contribute to SARS-CoV lung disease through reduced carboxypeptidase activity and changes in epithelial host defense signaling. There are 3 specific aims.
Aim 1. Determine how airway epithelial cell ACE2 expression is affected by SARS-CoV infection. In this aim we will investigate the hypothesis that pulmonary ACE2 expression in the vascular and epithelial compartments is regulated by cellular differentiation state, age, and mediators of infiammation and infection. We will also investigate how S-protein engagement and TACE affect sACE2 release.
Aim 2. Characterize the physiologic function of airway epithelial ACE2 during SARS-CoV infection. Here we emphasize detailed assessment of the enzymatic functions of ACE2 in the context of a local pulmonary RAS and kinin system and how they are perturbed during SARS-CoV infection and contribute to lung disease.
Aim 3. Identify enzyme activity-independent ACE2 functions that modulate host defense responses. For this aim, we focus on ACE2 function in airway epithelia independent of its receptor properties and carboxypeptidase activity. ACE2 effects that directly modulate epithelial host defenses will be studied.

Public Health Relevance

SARS-CoV caused severe morbidity and mortality in humans, yet there is sfill much that we do not understand about this virus and the determinants of pulmonary pathology. The studies of this proposal will investigate the role of the virus receptor and carboxypeptidase ACE2 in lung disease pathogenesis associated with SARS.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-EC-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Iowa City
United States
Zip Code
Park, Jung-Eun; Li, Kun; Barlan, Arlene et al. (2016) Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proc Natl Acad Sci U S A 113:12262-12267
Zuñiga, Sonia; Pascual-Iglesias, Alejandro; Sanchez, Carlos M et al. (2016) Virulence factors in porcine coronaviruses and vaccine design. Virus Res 226:142-151
Perlman, Stanley; Vijay, Rahul (2016) Middle East respiratory syndrome vaccines. Int J Infect Dis 47:23-8
Meyerholz, David K; Lambertz, Allyn M; McCray Jr, Paul B (2016) Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome. Am J Pathol 186:78-86
Vijay, Rahul; Perlman, Stanley (2016) Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Virol 16:70-6
Fehr, Anthony R; Channappanavar, Rudragouda; Jankevicius, Gytis et al. (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. MBio 7:
Zhang, Naru; Channappanavar, Rudragouda; Ma, Cuiqing et al. (2016) Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell Mol Immunol 13:180-90
Luke, Thomas; Wu, Hua; Zhao, Jincun et al. (2016) Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med 8:326ra21
Channappanavar, Rudragouda; Fehr, Anthony R; Vijay, Rahul et al. (2016) Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe 19:181-93
Alshukairi, Abeer N; Khalid, Imran; Ahmed, Waleed A et al. (2016) Antibody Response and Disease Severity in Healthcare Worker MERS Survivors. Emerg Infect Dis 22:

Showing the most recent 10 out of 80 publications